医薬品包装の世界市場予測（～2024年）...市場調査レポートについてご紹介

1 Introduction (Page No. – 18)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Pharmaceutical Packaging Market Segmentation
1.3.2 Regions Covered
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 21)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Data Triangulation
2.4 Assumptions
2.5 Limitations
3 Executive Summary (Page No. – 28)
4 Premium Insights (Page No. – 32)
4.1 Attractive Opportunities in the Pharmaceutical Packaging Market
4.2 Pharmaceutical Packaging Market, By Material
4.3 Pharmaceutical Packaging Market, By Type
4.4 Pharmaceutical Packaging Market, By Drug Delivery Mode
4.5 Pharmaceutical Packaging Market, By Region
4.6 North America Pharmaceutical Packaging Market, By Type and Country
5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Pharmaceutical Industry in Emerging Economies
5.2.1.2 Growing Demand for Drug Delivery Devices and Blister Packaging
5.2.1.3 Technological Advancements to Contribute to the Growth of Pharmaceutical Packaging
5.2.1.4 Growing Health Awareness and Adoption of New Regulatory Standards
5.2.2 Restraints
5.2.2.1 Increasing Overall Packaging Costs Owing to Dynamic Regulatory Policies
5.2.2.2 Lack of Access and Awareness in Emerging Markets
5.2.3 Opportunities
5.2.3.1 Growing Demand for Primary Pharmaceutical Packaging
5.2.3.2 Expanding 3pl and Other Services in Emerging Markets
5.2.4 Challenges
5.2.4.1 Safeguarding Against Counterfeit Products
5.3 Porter’s Five Forces Analysis
5.3.1 Threat of New Entrants
5.3.2 Threat of Substitutes
5.3.3 Bargaining Power of Buyers
5.3.4 Bargaining Power of Suppliers
5.3.5 Intensity of Competitive Rivalry
6 Pharmaceutical Packaging Market, By Type (Page No. – 44)
6.1 Introduction
6.2 Plastic Bottles
6.2.1 High Demand for Plastic Bottles Owing to Easy Workability and Lightweight Property
6.2.2 Standard Plastic Bottles
6.2.3 Plastic Dispensing Bottles
6.2.4 Plastic Jars
6.3 Blister Packs
6.3.1 Effective Drug Protection and Easy Manufacturing to Drive the Blister Packs Market
6.3.2 Compartment Packs
6.3.3 Wallet Packs
6.4 Labels & Accessories
6.4.1 Labels are Crucial in Ensuring Patient-Drug Communication Compliance
6.5 Caps & Closures
6.5.1 Plastic Caps & Closures are Expected to Witness High Growth During the Forecast Period
6.6 Medical Specialty Bags
6.6.1 Easy Handling and Disposable Characteristics are Increasing the Demand for Specialty Bags
6.7 Pre-Filled Syringes
6.7.1 Higher Patient Compliance and Increasing Aging Population are Driving the Demand for Pre-Filled Syringes
6.8 Temperature-Controlled Packaging
6.8.1 Increased Manufacturing of Specialized Drugs Will Fuel the Market for Temperature-Controlled Packaging
6.9 Pouches & Strip Packs
6.9.1 Increasing Demand for Standup Pouches Offers Growth Prospects for Packaging Manufacturers
6.10 Ampoules
6.10.1 Market for Ampoules in Developing Countries Witnessing A Good Growth Rate
6.11 Vials
6.11.1 Demand for Vials in Developed Countries Slowing Down
6.12 Pre-Filled Inhalers
6.12.1 Higher Demand Owing to Increasing Cases of Pulmonary Diseases Driving the Demand
6.12.2 Metered Dose Inhalers
6.12.3 Dry Powder Inhalers
6.13 Medication Tubes
6.13.1 Ease of Use is Driving Demand for Medication Tubes
6.13.2 Composite Tubes
6.13.3 All-Plastic Tubes
6.13.4 Collapsible Metal Tubes
6.14 Jars & Canisters
6.14.1 Canisters Help Extend Shelf-Life of Pharmaceutical Products
6.15 Cartridges
6.15.1 Increasing Use of Pre-Filled Syringes Driving the Demand
6.16 Others
7 Pharmaceutical Packaging Market, By Raw Material (Page No. – 59)
7.1 Introduction
7.2 Plastics & Polymers
7.2.1 Excellent Shatter Resistant of Plastics & Polymers Boosts Its Use in Primary Packaging
7.2.2 High-Density Polyethylene
7.2.3 Polyester
7.2.4 Polypropylene
7.2.5 Low-Density Polyethylene
7.2.6 Polyvinyl Chloride
7.2.7 Cyclic Olefin Copolymer
7.2.8 Polyethylene Terephthalate
7.3 Paper & Paperboards
7.3.1 Innovations in Secondary Packaging to Propel the Use of Paper & Paperboards
7.4 Glass
7.4.1 Excellent Chemical Resistance of Glass to Boost Its Use in Primary Packaging
7.5 Metals
7.5.1 Increasing Use of Aluminium for Blister Packaging to Boost the Market for Metals Segment
7.6 Others
8 Pharmaceutical Packaging Market, By Drug Delivery Mode (Page No. – 67)
8.1 Introduction
8.2 Oral Drug Delivery Packaging
8.2.1 High Demand for Oral Drug Delivery Owing to Ease of Usage
8.3 Pulmonary Drug Delivery Packaging
8.3.1 Increasing Cases of Lung-Related Diseases Driving Demand
8.4 Transdermal Drug Delivery Packaging
8.4.1 Increasing Small Dose Drug Usage Fueling Market for Transdermal Drug Delivery Packaging
8.5 Injectable Packaging
8.5.1 Injectables Offer Improved Patient Compliance
8.6 Topical Drug Delivery Packaging
8.6.1 Prevalence of Skin Diseases Drives the Market for Topical Drugs
8.7 Nasal Drug Delivery Packaging
8.7.1 Rapid Absorption and Faster Onset of Action Propelling the Use of Nasal Drug Systems
8.8 Ocular Drug Delivery Packaging
8.8.1 Increasing Prevalence of Eye Disorders in the Aging Population Expected to Fuel the Consumption of Ocular Drugs Packaging
8.9 Iv Drugs Delivery Packaging
8.9.1 Growing Use Due to Improved Patient Compliance and High Drug Dose Capability Driving the Demand
8.1 Other Drugs Delivery Packaging
9 Pharmaceutical Packaging Market, By Region (Page No. – 73)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Pharmaceutical Packaging Market has Reached New Heights With Rapid Technological Advancements
9.2.2 Canada
9.2.2.1 The Country Provides A Competitive Business Environment for Pharmaceutical Packaging Manufacturers
9.2.3 Mexico
9.2.3.1 Government Initiatives in the Healthcare Industry are Aiding High Demand for Pharmaceutical Packaging
9.3 Europe
9.3.1 Germany
9.3.1.1 Need for Advanced Drug Delivery Systems Due to the Increasing Aging Population and Non-Communicable Diseases is the Main Reason for the Growth of the Pharmaceutical Packaging Market
9.3.2 France
9.3.2.1 The Demand for Generic Drugs in the Country is Growing
9.3.3 Italy
9.3.3.1 Growing Exports of Pharmaceuticals Have A Significant Impact on the Market
9.3.4 UK
9.3.4.1 Innovations in the Pharmaceutical Industry are Increasing the Demand for Pharmaceutical Packaging
9.3.5 Spain
9.3.5.1 Government Initiatives in the Healthcare Sector Will Boost the Demand for Pharmaceutical Packaging
9.3.6 Russia
9.3.6.1 Government Initiatives for Domestic Production of Pharmaceuticals are Driving the Pharmaceutical Packaging Market
9.3.7 Rest of Europe
9.4 APAC
9.4.1 China
9.4.1.1 The Government is Investing in R&D With A Special Focus on Biologics and Biosimilar Drugs
9.4.2 Japan
9.4.2.1 The Sizeable Aging Population is Increasing the Demand for Medications
9.4.3 South Korea
9.4.3.1 The Country has A Well-Developed Healthcare Industry and Houses Major Pharmaceuticals Manufacturers
9.4.4 India
9.4.4.1 Large Domestic Consumption of Pharmaceuticals and Export of Generic Drugs are Driving the Pharmaceutical Packaging Market
9.4.5 Australia
9.4.5.1 Schemes Such as Medicare and Pbs are Strengthening the Country’s Pharmaceutical Industry
9.4.6 Rest of APAC
9.5 South America
9.5.1 Brazil
9.5.1.1 Free and Universal Healthcare Services Supporting the Growth of the Pharmaceutical Industry
9.5.2 Argentina
9.5.2.1 The Population has Good Access to Generic Drugs Supported By Government Initiatives
9.5.3 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.1.1 Wider Access to Healthcare Services is Increasing the Demand for Pharmaceuticals
9.6.2 South Africa
9.6.2.1 A Gradual Rise in Generic Drug Usage Will Fuel the Pharmaceutical Packaging Market
9.6.3 Egypt
9.6.3.1 Increasing Domestic Production and Consumption of Pharmaceuticals Show Potential Market Growth
9.6.4 Rest of the Middle East & Africa
10 Competitive Landscape (Page No. – 110)
10.1 Overviews
10.2 Competitive Leadership Mapping, 2018
10.2.1 Visionary Leaders
10.2.2 Innovators
10.2.3 Dynamic Differentiators
10.2.4 Emerging Companies
10.3 Competitive Benchmarking
10.3.1 Strength of Product Portfolio
10.3.2 Business Strategy Excellence
10.4 Market Ranking of Key Players
10.4.1 Berry Global Inc.
10.4.2 Gerresheimer AG
10.4.3 Amcor PLC
10.4.4 Schott AG
10.4.5 Aptargroup, Inc.
10.5 Competitive Situation & Trends
10.5.1 New Product Launch
10.5.2 Investment & Expansion
10.5.3 Merger & Acquisition
10.5.4 Agreement & Collaboration
10.5.5 Joint Venture
11 Company Profiles (Page No. – 124)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 Berry Global Inc.
11.2 Gerresheimer AG
11.3 Amcor PLC
11.4 Schott AG
11.5 Aptargroup, Inc.
11.6 Becton, Dickinson and Company
11.7 Catalent, Inc.
11.8 Nipro Corporation
11.9 West Pharmaceutical Services, Inc.
11.10 Westrock Company
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies
11.11 Others
11.11.1 Alpla Werke Alwin Lehner GmbH & Co Kg
11.11.2 Ardagh Group S. A.
11.11.3 CCL Industries Inc.
11.11.4 Frank Noe Egypt Ltd
11.11.5 Gaplast GmbH
11.11.6 Lonza Group Ltd
11.11.7 Mondi Group
11.11.8 Nolato AB
11.11.9 Origin Pharma Packaging
11.11.10 Owens-Illinois, Inc.
11.11.11 Parekhplast India Ltd.
11.11.12 SGD Pharma
11.11.13 Silgan Holdings Inc.
11.11.14 Stevanato Group
11.11.15 Vetter Pharma International GmbH
12 Appendix (Page No. – 154)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details